Zhejiang Ausun Pharmaceutical Co Ltd - Class A

SHSE:603229 (China)   Class A
Â¥ 11.61 (+2.38%) Apr 30
23.65
P/B:
3.04
Market Cap:
Â¥ 6.89B ($ 950.92M)
Enterprise V:
Â¥ 6.07B ($ 838.83M)
Volume:
10.97M
Avg Vol (2M):
5.35M
Volume:
10.97M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Zhejiang Ausun Pharmaceutical Co Ltd ( ) from 2017 to May 02 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zhejiang Ausun Pharmaceutical stock (SHSE:603229) PE ratio as of May 02 2024 is 23.65. More Details

Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) PE Ratio (TTM) Chart

To

Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) PE Ratio (TTM) Historical Data

Total 1176
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Zhejiang Ausun Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-02 25.2 2024-02-26 24.9
2024-04-30 25.2 2024-02-23 24.7
2024-04-29 24.6 2024-02-22 24.6
2024-04-26 22.8 2024-02-21 24.3
2024-04-25 22.6 2024-02-20 24.1
2024-04-24 21.9 2024-02-19 23.8
2024-04-23 21.7 2024-02-08 23.9
2024-04-22 21.6 2024-02-07 22.1
2024-04-19 20.8 2024-02-06 21.1
2024-04-18 21.1 2024-02-05 19.6
2024-04-17 21.7 2024-02-02 21.4
2024-04-16 20.8 2024-02-01 23.0
2024-04-15 21.5 2024-01-31 22.9
2024-04-12 22.0 2024-01-30 24.3
2024-04-11 22.2 2024-01-29 25.2
2024-04-10 22.9 2024-01-26 25.7
2024-04-09 22.7 2024-01-25 26.4
2024-04-08 21.7 2024-01-24 25.3
2024-04-03 22.7 2024-01-23 25.4
2024-04-02 22.6 2024-01-22 24.9
2024-04-01 22.9 2024-01-19 26.6
2024-03-29 22.1 2024-01-18 27.1
2024-03-28 22.2 2024-01-17 27.1
2024-03-27 23.6 2024-01-16 28.0
2024-03-26 24.1 2024-01-15 28.2
2024-03-25 24.3 2024-01-12 28.3
2024-03-22 25.3 2024-01-11 28.7
2024-03-21 25.9 2024-01-10 28.2
2024-03-20 26.2 2024-01-09 28.4
2024-03-19 25.9 2024-01-08 28.6
2024-03-18 26.2 2024-01-05 29.3
2024-03-15 25.9 2024-01-04 30.0
2024-03-14 25.8 2024-01-03 30.4
2024-03-13 25.6 2024-01-02 30.6
2024-03-12 25.4 2023-12-29 30.7
2024-03-11 24.6 2023-12-28 30.4
2024-03-08 24.1 2023-12-27 26.8
2024-03-07 24.1 2023-12-26 26.4
2024-03-06 24.8 2023-12-25 27.3
2024-03-05 25.0 2023-12-22 27.3
2024-03-04 25.6 2023-12-21 27.5
2024-03-01 25.1 2023-12-20 27.6
2024-02-29 25.1 2023-12-19 28.1
2024-02-28 24.6 2023-12-18 28.2
2024-02-27 25.5 2023-12-15 28.4

Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.